Morgan Stanley’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
ACM
RA
DCM
JGC
ACM
SPM
LK
XT
Morgan Stanley's PYPD Position: Q1 2026 in Review
Morgan Stanley reduced its PolyPid (PYPD) stake by 15% in Q1 2026, selling an estimated $139K and leaving 176,892 shares worth $775K. The position accounts for ﹤0.01% of the portfolio, ranked #5279.
Morgan Stanley first reported a position in PYPD in Q2 2021 and has held it in 20 quarters since. The position peaked at $904K in Q4 2025. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.
- Morgan Stanley held 176,892 shares of PolyPid worth $775K as of Q1 2026.
- Morgan Stanley sold 31,386 PolyPid shares in Q1 2026, an estimated $139K.
- PolyPid made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5279 holding.
- Morgan Stanley first reported a position in PolyPid in Q2 2021 and has held it in 20 quarters since.
- Morgan Stanley's PolyPid position peaked at $904K in Q4 2025.
- 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.